Loading…
US stock · US markets · public data
RPRX
Royalty Pharma plc · Healthcare
Reference price$58.21Updated according to the public source
P/E30.99
P/B3.80
ROE12.36%
DY 12M1.77%
Net margin32.13%
Debt/equity1.31
Market capUS$ 33.5 B
Volume (shares)2,980,000
SectorHealthcare
Overview
Indicadores públicos consolidadosAbout RPRX
Royalty Pharma plc (RPRX) is a stock traded in US markets in the Healthcare sector. P/E 30.99, P/B 3.80, ROE 12.36% and dividend yield 1.77%. The P/E multiple helps compare this asset's valuation with other companies in the same sector. Explore the public market data tracked by FundamentalRadar. This page includes key fundamental indicators, recent distributions and financial statements available from the public sources tracked by FundamentalRadar.
Distributions
public dataDividends and distributions · last 12 records
The source returned no recent distributions for this asset.
Financials
No dataIncome statement, balance sheet and cash flow
Financial statements are not available for this asset yet.
FAQ
Frequently asked questions
What is the price of RPRX?
The current price of RPRX is $58.21.
What is the P/E of RPRX?
The P/E ratio of RPRX is 30.99, meaning investors pay 30.99 times earnings per share.
What is the P/B of RPRX?
The P/B of RPRX is 3.80, meaning the stock trades at 3.80 times its book value per share.
What is the ROE of RPRX?
The ROE (Return on Equity) of RPRX is 12.36%, meaning the company generates 12.36% of profit for every unit of shareholders' equity.
What is the dividend yield of RPRX?
The dividend yield of RPRX is 1.77%. This represents the annual dividend relative to the current share price.
What is the market cap of RPRX?
The market capitalization of RPRX is US$ 33.5 B.
What is the net margin of RPRX?
The net profit margin of RPRX is 32.13%, meaning the company keeps 32.13% of revenue as profit.
What is the debt-to-equity ratio of RPRX?
The debt-to-equity ratio of RPRX is 1.31, meaning the company has 1.31 units of debt for each unit of equity.
What sector is RPRX in?
RPRX operates in the Healthcare sector.